Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Mentholatum Greaseless Vaporizing Cream** is an over-the-counter topical combination drug developed and marketed by **The Mentholatum Company** for symptomatic relief of cough and minor musculoskeletal pain. It is a **small-molecule topical cream** containing **camphor**, **eucalyptus oil**, and **menthol**. Its pharmacologic effect is nonspecific and is mediated primarily through topical counterirritant actions and inhalation of aromatic vapors rather than a single defined molecular target. When applied to the chest or throat, the volatile ingredients provide temporary relief of cough associated with throat or lung irritation; when applied to muscles or joints, the formulation provides temporary relief of minor aches and pains. The product is designed as a non-greasy, fast-absorbing cream with a citrus scent and is labeled for adults and children 2 years and older.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mentholatum Greaseless Vaporizing Cream.